Dennis Keefe
Company: Complement Therapeutics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Discussing the Next-Generation of Novel Modalities to be Used for Enhanced Delivery & Broader Impact in CNS & Ophthalmic Indications 12:00 pm
Addressing the critical challenge of achieving sufficient complement inhibitor exposure in the CNS, a major reason for past failures with peripherally acting drugs Exploring novel delivery modalities like gene therapy, shuttle technologies that are in early development, to unlock the therapeutic potential of complement inhibition neurodegenerative diseases Highlighting the significant appeal and ongoing development of…Read more
day: Conference Day Two
Rethinking the Delivery of Complement-Based Therapeutics to Ensure Complement Moderators are Reaching the Correct Targets in the Appropriate Quantities 2:30 pm
Join this workshop to deepen your understanding of the approaches being used to overcome the challenges in effectively delivering complement mediators to their target tissues and discuss optimal dosages for complement-based therapeutics for different organs. Understanding organ-specific differences and their implications for developing effective complement targeted therapies from a drug delivery perspective Exploring alternatives to…Read more
day: Pre-Conference Workshop Day